OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story
Source: SeekingAlpha
2025-12-23 10:03:58 ET
This article continues my coverage of OptimizeRx ( OPRX ). I last wrote about OPRX back in July 2025 . The company's Q3 2025 earnings results reinforce my long-term bullish thesis for the stock....
Read the full article on Seeking Alpha
For further details see:
OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story
OptimizeRx Corporation
NASDAQ: OPRX
OPRX Trading
2.29% G/L:
$6.915 Last:
182,880 Volume:
$6.85 Open:
OPRX Latest News
March 05, 2026 05:04:30 pm
UPDATE - OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026 04:01:00 pm
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
OPRX Stock Data
$189,855,041
17,596,775
3.29%
31
N/A
Healthcare Providers & Services
Healthcare
US
Waltham
